Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 March 2025 | Story Tshepo Tsotetsi | Photo Supplied
Human Rights Month 2025
UFS: Promoting human rights and empowering equality every day.

As we celebrate Human Rights Month, the University of the Free State (UFS) remains committed to fostering a campus culture where human rights are actively upheld and respected. This ongoing dedication aligns with Vision 130, a guiding principle that drives the UFS’s efforts in creating an inclusive, equitable environment for students, faculty, and staff.

 

Fostering a human rights-centred education through Vision 130

At the heart of the UFS’s mission is Vision 130, a strategic framework aimed at positioning the university as a leader in inclusivity, social justice, and academic excellence. It ensures that the university’s commitment to human rights and equality is reflected not only in academic programmes but also in everyday student and staff interactions.

For students like Nomathemba Mhlafu, a final-year Bachelor of Arts student majoring in Psychology, these principles resonate deeply. “Honestly, it’s about having the right to education and access to resources,” Mhlafu says. “The fact that I can come here, study, and actually get my degree? That’s everything.”

 

Human rights: A shared responsibility

The promotion of human rights at the UFS is not only an institutional effort but one that includes students, faculty, and staff. Martie Miranda, Head of the UFS’s Centre for Universal Access and Disability Support (CUADS), emphasises that promoting inclusivity for persons with disabilities requires a unified effort. She underscores that staff must provide accessible communication, including principles such as using clear, simple language in written and verbal communication and ensuring that alternative formats for documents, such as braille, large print, or digital versions, are available.

Miranda stresses the importance of respect and awareness. “Students need to treat students with disabilities with respect and dignity, being mindful of ableism and microaggressions,” she says. This everyday care practice ensures that all students, regardless of ability, can thrive.

Similarly, Oratile Lentsela, CSRC for Universal Access, advocates for a campus that embraces all students, regardless of background or ability. “We must continue to raise awareness and remove barriers to learning,” she says. “This includes creating more accessible spaces and improving support services.”

 

The role of students in shaping a human rights-conscious campus

Students are at the core of shaping a campus that is both human rights-conscious and inclusive. Dr Annelie De Man, Division Coordinator of the Advocacy Division at the Free State Centre for Human Rights, says, “Students have an indispensable role to play in ensuring that they are not only aware of the rights that they possess as human beings, but also the means available to them in situations where their rights are not respected, protected, and/or fulfilled.”

 

According to Dr De Man, students can contribute by:

• Creating or joining student associations that advocate for human rights.
• Educating peers on human rights and redress mechanisms through workshops and discussions.
• Demonstrating inclusivity and respect by fostering a welcoming environment for students from diverse backgrounds.
• Engaging in social justice discussions and contributing to solutions for addressing injustices.

• Providing peer support and guiding affected students to appropriate reporting channels when human rights violations occur.

Furthermore, the Human Rights Ambassadors programme, an initiative led by the Advocacy Division, empowers students to take the lead in promoting human rights within their residences. Ambassadors organise events such as poetry performances, debates, and awareness campaigns to inspire a culture of human rights on campus.

 

Public engagement as a step forward in human rights advocacy

As part of its ongoing efforts, the Free State Centre for Human Rights continues to host a variety of events to promote human rights awareness. Dr De Man highlights the importance of events like public lectures, seminars, and workshops in raising critical discussions about human rights. One such event is the centre’s first annual public lecture on 19 March 2025, which will feature Prof JL (Loot) Pretorius presenting on ‘Courts, Human Rights, and Democracy’.

“The collaboration between the different divisions of the centre allows us to engage the wider university community on issues of great importance,” Dr De Man notes. The upcoming lecture will provide a platform for the UFS community to reflect on the intersection of law, human rights, and democracy in South Africa.

 

A rights-conscious campus for all

A commitment to human rights is integral to both the UFS’s daily operations and long-term vision. Through initiatives like the Human Rights Ambassadors, the work of CUADS, and student leadership, the UFS continues to build a campus environment that prioritises equality, inclusivity, and social justice.

Mhlafu says this commitment extends beyond academics for her. “I had an injury once and went to Kovsie Clinic for help. It’s a service that’s always available to students, every day,” she explains. “That was a moment where I really saw how important the right to healthcare is. You don’t think about it until you need it, and when you do, it makes a huge difference.”

In line with Vision 130, the UFS remains steadfast in its dedication to providing every student with the resources, education, and support they need to succeed. With human rights at the forefront of every effort, the UFS is creating a campus where all individuals are empowered to thrive, ensuring that respect, dignity, and equality are not just ideals but a lived reality.

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept